Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 4,957-4,968 of 10,612

Device study icon

CompletedNCT01567982

Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDeviceFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

TerminatedNCT03838484

Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Schizophrenia

Drug study icon

CompletedNCT00218218

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionDrugFrom 18 Years to 80 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT00829881

Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 22 Years to 55 Years

Countries: United States
Sponsor: P2D, Inc.
Condition: ADHD

Drug study icon

CompletedNCT00731055

Effects of Varenicline on Cigarette Self Administration

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Drug study icon

CompletedNCT01524627

Effects of Varenicline on Smoking Reminders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Device study icon

CompletedNCT06902727

Effects of Virtual Reality Exercise on Promoting Physical Activity and Health Among College Students

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

DepressionDeviceFrom 18 Years to 35 Years

Countries: United States
Sponsor: The University of Tennessee, Knoxville
Condition: Depression

Device study icon

CompletedNCT06804967

Effects of Virtual Reality Relaxation on the Anxiety Levels

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AnxietyDeviceOver 13 Years

Countries: United States
Sponsor: Indiana University
Condition: Anxiety

Drug study icon

CompletedNCT00455702

Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Schizophrenia

Behavioral study icon

CompletedNCT05314153

Effects Zulresso on Postpartum Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Schizophrenia

Drug study icon

CompletedNCT00085891

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

CompletedNCT00107731

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: AstraZeneca
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.